Determination of la,25-dihydroxyvitamin D [1,25(OH)2D, gross amounts of 1,25(OH)2D2 and 1,25(OH)2D3] and separative deter mination of 1,25(OH)2D2 and 1,25(OH)2D3 in plasma using calf thymus receptor have been investigated. A lipid extract from 1ml of plasma is applied to a Bond Elut C180H column and an eluate corresponding to 1,25 (OH)2D including both 1,25(OH)2D2 and 1,25(OH)2D3 is applied to calf thymus receptor to assay a gross amount of the two compounds. On the other hand, when separative assay of the two compounds is performed, the 1,25 (OH)2D eluate obtained from the Bond Elut C180H column is further applied to HPLC using a Zorbax SIL column with 5% isopro panol in methylene chloride as a developing solvent to separate the two compounds from one another. The separated eluates are independently applied to the receptor to assay the two compounds. Since less amounts of unknown components non-specifically bound to interfering concomi tants besides 1,25(OH)2D exist in the calf thymus receptor, complicated purification steps to eliminate the concomitants are unnecessary. The detection limit by this method is 1.25 pg/tube which is sensitive enough for a routine method to assay 1,25(OH)2D in plasma. Key Words vitamin D, 1,25-dihydroxyvitamin D, 1,25-dihydroxyvitamin D2, 1,25-dihydroxyvitamin D3, radioreceptor assay, calf thymus receptor Vitamin D (vitamin D is used as a general name for vitamins D2 and D3 and the same nomenclature system is also applied to the metabolites) is metabolized to in the liver and subsequently to la,25-dihy droxyvitamin D (1,25(OH)2D) or 24R,25-dihydroxyvitamin D (24,25(OH)2D) in the kidney (1, 2). 1,25(OH)2D is known as an active form of vitamin D which promotes intestinal calcium absorption and remodeling in bone to keep calcium homostasis. Recent investigations have revealed that 1,25(OH)2D has the activity
in suppressing proliferation and inducing cell differentiation besides the calcemic activity (3, 4) . The finding has accelerated clinical uses of 1 ,25 (OH)2D3 and la-hydroxyvitamin D3 (la-OH-D3) as a prodrug of 1,25(OH)2D3 to leukemia , psoriasis, skin cancer, and other diseases. According to the development of clinical uses, establishment of a simplified and precise method for determination of 1 ,25 (OH)2D in plasma has been required for clinical studies. However, since plasma levels of 1,25(OH)2D are extremely low (normal range: 20-80pg/ml) , it is very difficult to establish a simplified and precise method. Since high-performance liquid chromatography (HPLC) using an ultraviolet (UV) detector and gas-liquid chro matography/mass spectrometry (GC-MS) cannot be applied to the determination of 1,25(OH)2D in plasma because of their low sensitivity (5) , radioreceptor assay (RRA) is now most popular for the purpose (6) (7) (8) (9) (10) (11) (12) (13) . Cytosol-chromatin receptors (6-13) have been used for RRA. Recently, Reinhardt et al. (14) isolated a receptor from calf thymus showing high affinity to 1,25 (OH)2D and established a method for the determination using the receptor (15) . Hollis (16) also reported a non -HPLC method for determination of 1,25(OH)2D HPLC method for determination of 1,25 (OH)2D using C180H column and the receptor . Since calf thymus receptor is now commercially available, we have studied gross and separative determination of 1,25(OH)2D2 and 1,25(OH)2D3 in plasma using the receptor .
EXPERIMENTAL
Apparatus. Vac Elut SPS-24 (Analyticalchem International Co ., USA) was used as a sample processing station for use with Bond Elut C180H cartridge column (C18OH column). HPLC was performed with a high-performance liquid chroma tograph (LC6A, Shimadzu Co., Kyoto, Japan) equipped with an ultraviolet (UV) detector (SPD-6A, Shimadzu Co.). Radioactivities were measured by a liquid scintillation counter (LSC-700, Aloka Co., Tokyo, Japan) .
Compounds and reagents. ,25(OH)2D3 was applied to the proposed procedure described in the text and a profile of C180H column chromatography was described by radioactivity and receptor binding affinity with calf thymus receptor. The 1,25(OH)2D fraction eluted from the column was further applied to HPLC using a Zorbax SIL column and a profile was described by UV absorption at 265nm, radioactivity and binding affinity with calf thymus receptor. values 11.7 and 8.1%, respectively.
A liquid extract from a plasma sample was applied to a C180H column and the 1,25(OH)2D fraction was further applied to HPLC using a Zorbax SIL column with 5% isopropanol in methylene chloride. Figure 3 shows the chromatographic profiles described by radioactivity, receptor binding, and UV absorption. Although the two peaks due to receptor binding were observed in the profiles of C18OH column chromatography, no receptor binding other than 1,25 (OH)2D was ob served in the profile of HPLC. The assayed values (29.8pg/ml) of 1,25 (OH)2D in the 1,25(OH)2D fraction of C180H column chromatography was close to that after application to the HPLC (33.3pg/ml). These results suggest that existing interfer ing substance in plasma can be effectively eliminated by the C180H column chromatography alone and no further purification by HPLC is necessary for assaying 1,25(OH)2D. Figure 4 shows comparison of chick embryonal intestinal (9) and calf thymus receptors. A lipid extract from a plasma sample was purified by the three steps of HPLC described in our previous report (13) and applied to both chick intestinal and calf thymus receptors. The assayed values of 1,25 (OH)2D by the two methods were 49.6 and 59.8pg/ml, respectively, which were close to one another. On the Comparison of values in a plasma sample assayed by RRA using either chick intestinal or calf thymus receptors. A plasma sample containing 2,000 dpm of [3H]-1,25(CH)2D3 was applied to the procedure described in a previous paper (13) and the 1,25(OH)2D fraction purified by application to the 3 steps of HPLC was applied to RRA using either chick intestinal or calf thymus receptor to determine concentrations of 1,25(OH)2D (upper panel). In contrast, the same plasma sample was applied to the procedure described in the text and the 1,25(OH)2D fraction eluted from a C180H column was successively applied to the 3 steps of HPLC described in a previous paper (13) . Each 1,25(OH)2D fraction obtained by each step was applied to RRA using either chick intestinal or calf thymus receptor (lower panel).
otherr hand, when the same lipid extract was purified by the C18OH column alone and the eluate corresponding to 1,25(CH)2D was directly applied to either chick intestinal or calf thymus receptor, the assayed values were 114.2 and 52.5pg/ml, respectively-quite different from one another. When the eluates were successively applied to the three steps of HPLC and each 1,25(OH)2D fraction was applied to RRAA using either chick intestinal or calf thymus receptor, the high value by chick intestinal receptor decreased after applying to the 2nd steps of HPLC while the values by the calf thymus receptor were not changed after applying to the 3 steps of HPLC as shown in Fig. 4 . The results suggest that the amounts of unknown components nonspecifically bound to interfering concomitants besides 1,25(OH)2D in the calf thymus receptor were smaller than those in the chick intestinal receptor. Therefore, a complete clean-up procedure using at least two steps of HPLC (or a Sep-Pak silica cartridge and one step of HPLC) is necessary to eliminate interfering substances in the assay using chick intestinal receptor, A plasma sample containing 2,000dpm of [3H]m1,25(OH)2D3 was applied to the proposed procedure described in the text and the 1,25 (OH)2D fraction eluted from a C18OH column was successively applied to the 3 steps of HPLC described in a previous paper (13) . Each profile at each step was described by UV absorption at 265 nm, radioactivity and binding affinity with chick intestinal receptor.
whereas a simple clean-up procedure using a C180H column alone is enough to perform the assay of 1,25(OH)2D by calf thymus receptor because of its specificity to 1,25(OH)2D. In order to clarify the properties of interfering concomitants non-specifically bound to the chick intestinal receptor, a lipid extract from a plasma sample was applied to the C18OH column and the 1,25(OH)2D fraction was successively applied to the 3 steps of HPLC. Figure 5 shows the chromatographic profiles described by radioactivity and receptor binding. Many peaks due to receptor binding were observed in the profiles of the 1st step of HPLC and these included both less and more polar than 1,25(OH)2D. The profile of the 2nd step of HPLC still showed the existence of both less and more polar interfering substances than 1,25(OH)2D. The profile of the 3rd steps of HPLC showed a single peak corresponding to 1,25 (OH)2D and those of the interfering substances were elimi nated from the 1,25(OH)2D fraction. The results suggest that the 1,25(OH)2D fraction obtained from the 1st step of HPLC still contained interfering substance to chick intestinal receptor which could be separated from 1,25(OH)2D by the 2nd step of HPLC, because the profile of the 3rd step of HPLC gave a receptor binding 3) Assayed values of 1,25(OH)2 D in plasma. Plasma samples obtained from humans (normal subjects and patients with diabetes mellitus, hypoparathyroidism, primary hyperparathyroidism, and osteoporosis) and rats (normal and vitamin D-deficient rats) were applied to the proposed method to determine concentrations of 1,25(OH)2D. As shown in Fig. 6 , satisfactory results were obtained. 4) Correlation between the assayed values obtained by the proposed method and a previously reported method. Figure 7 shows the correlation between the assayed values obtained by the presently proposed method using calf thymus receptor and the previously reported method using chick intestinal receptor with three steps of HPLC (13) . A significant correlation was observed between the two (p<0.01). by the C,8OH column. Since the two compounds were eluted in the same fraction, the eluaee was successively applied to HPLC to separate the both compounds. Figure 8b shows an HPLC profile of standard compounds of 1,25(OH)2D2 and 1,25(OH)2D3. Since the two compounds were clearly separated from one another, separative assay of the both compounds can be achieved by applying each separated eluate to RRA using calf thymus receptor. When plasma samples were applied to the proposed method with addition of 50 pg of standard compounds of either 1,25(OH)2D2 or 1,25 (OH)2 D3, averaged analytical recoveries were 95.8 and 113.4% for 1,25 (OH)2D2 and 1,25 (OH)2D3, respectively, which were satisfactory. 2) Comparison between the values of 1,25(OH)2D2 and 1,25(OH)2D3 assayed by the presented proposed and previously reported methods. Table 2 shows compar ison between the values of 1,25(OH)2D2 and 1,25(OH)2D3 assayed by the presently proposed method using calf thymus receptor and a previously reported method using chick intestinal receptor (13) . Significant correlations were observed between the respective values.
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DISCUSSION
In the last decade, a number of assay methods for 1,25(OH)2D in plasma has been reported by using biological procedures, is e., bioassay (17) , RRA (6-16), and radioimmunoassay (RIA) (18, 19) . These methods have shown great advantages in sensitivity and specificity. Although physicochemical methods using GC-MS (5) are very attractive, these have not yet been developed as routine methods in biological fluids. RIA has been developed by using antisera raised against 3 or 25 -hemisuccinate of 1,25 (OH)2D3 (18, 19) , but a good antibody with high sensitivity has not been obtained. RRA has been developed by many research groups (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) and it is most popular as a routine method for determination of 1,25 (OH)2D in plasma because of its high sensitivity. In a previous paper (13), we have established a method for determination of 1,25(OH)2D using chick embryonal intestinal receptor. However, since the receptor contains significant amounts of unknown components non-specifically bound to interfering concomitants besides 1,25(OH)2D, two or three clean-up steps using HPLC are required to avoid an unexpected abnormal value due to interfering concomitants. Reinhardt et al. (15) isolated 1,25(OH)2D receptor from calf thymus and established an assay method for 1,25(OH)2D using the receptor with Silica Sep-Pak and C18 Silica cartridges for cleanup without use of HPLC. Ho11is (16) revised the method to a simplified one by using the C180H column which can be used as reversed solid-phase extraction and subsequent normal phase purification. Since the RRA method has been simplified by use of C180H column in the purification step, a kit with combined use of the column and calf thymus receptor has been commercially available and we have checked the kit to establish simplified methods for gross and reparative determination of 1,25(OH)2D2 and 1,25(OH)2D3 in plasma.
As shown in Fig. 4 , when a lipid extract obtained by a plasma sample was applied to chick embryonal intestinal and calf thymus receptors after purification by the C180H column to compare the receptors with one another, an abnormally high value was obtained by the chick intestinal receptor but not by the calf thymus receptor. The high value by the former diminished by stepwisely applying the eluate to HPLC. The results suggest that the amounts of unknown components non-specifically bound to interfering concomitants besides 1,25(OH)2D in the calf thymus receptor are smaller than those in the chick intestinal receptor. Kubo et al. (20) also observed that chick embryonal intestinal receptor contained large amounts of such interfering components which could be eliminated by a purifi cation step using precipitation with ammonium sulfate solution. The results suggested that low specificity observed in the chick embryonal intestinal receptor might be due to existence of unknown protein impurities. They also checked specificity of calf thymus receptor by reaction with 1,25(OH)2D fraction of a serum sample obtained through a C180H column and found that existence of impurities was much lower than in chick embryonal intestinal receptor. However, nonspecific binding components were still observed in the fractions other than 1,25(OH)2D though these were not so large, while our used commercial kit in this study showed no other binding reaction than 1,25(OH)2D fraction as shown in Fig . 3 . The results suggest that our used receptor is more pure than that used by Kubo et al . (20) .
A simple clean-up procedure using only a C180H column is sufficient to perform the assay of 1,25 (OH)2D by calf thymus receptor. This is a big merit for determination of 1,25(OH)2D, because omitting HPLC is not only time-saving but also gives the possibility for simultaneous assay of many samples due to use of cheap open columns. As shown in Fig. 7 , there is a significant correlation between the values obtained by the presently proposed method using calf thymus receptor and the previous method using chick intestinal receptor with three steps of HPLC (13) . These results suggest that the proposed method using the calf thymus receptor can be widely available as a routine one for determination of 1 ,25(OH)2D in plasma.
There are two forms of vitamin D, namely D2 and D3 , which are structurally different in the side chains, but they are similarly metabolized into 1 ,25 (OH)2D2 and 1,25 (OH)2D3 via 25-OH-D2 and 25-OH-D3 to show physiologically similar activity in mammals including humans (1, 2) . Since vitamin D2 is not bio synthesized in the body (21) , all of the D2 compounds detected in the body are derived from exogenous sources, for instance, multivitamin preparations , enriched foods and Shiitake mushroom. Hartwell et al. (22) orally administered 4 ,000 IU/day of vitamin D2 to healthy premenopausal women for 8weeks and observed the changes in plasma levels of 1,25 (OH)2D2 and 1,25 (OH)2D3 . The plasma levels of 1,25(OH)2D2 increased (from an undetected level to 31pg/ml) with decrease of 1,25(OH)2D3 levels (from 42 to 19pg/ml) to keep a constant level of 1 ,25(OH)2D
(from 42 to 50pg/ml). We also observed that oral administration of 400IU/day of vitamin D2 to healthy male subjects for 44weeks increased the plasma levels of 1,25 (OH)2D2 (from an undetected level to 29.8pg/ml) with keeping gross levels of 1,25(OH)2D within the normal range (23) . These results suggest that strict feedback regulation of la-hydroxylation occurs from 25-OH-D to 1 ,25 (OH)2D in the kidney without distinguishing the D2 and D3 compounds. These results are very interesting in the field of vitamin D2 and D3 studies. Therefore , establishment of a simplified method for separative determination of 1,25(OH)2D2 and 1,25(OH)2D3 plasma is very important to perform the studies in the fields of vitamin D2 and its analogs, for instance, 25-OH-D2, 1,25 (OH)2 D2, and 1 a-OH-D2. When a 1,25 (OH)2D fraction obtained from the CI3OH column chromatography in the proposed method described above was applied to the HPLC, 1,25(OH)2D2 and 1,25(OH)2D3 were clearly separated from one anotherr as shown in Fig . 8a . The both compounds were satisfactorily determined by applying each separated fraction to RRA using calf thymus receptor. As shown in Fig. 2, 1 ,25(OH)2D2 gave a calibration curve nearly the same as that of 1,25(OH)2D3 and the result suggests that a calibration curve described by a standard compound of 1,25(OH)2D3 is also available for determination of 1,25 (OH)2D2. This is very convenient , because a standard compound of 1,25(OH)2D3 is easy to get in commercial markets while a standard compound of 1,25(OH)2D2 should be obtained by chemical synthesis or in vitro formation using chick or rat kidney homogenates.
In conclusion, we have established sensitive and simplified methods for gross and separative determination of 1,25(OH)2D2 and l,25(OH)2D3 in plasma using calf thymus receptor. These are useful as routine methods for determination of gross amounts of 1,25(OH)2D2 and 1,25(OH)2D3 and separative determination of the two compounds. These will contribute to development of clinical studies in future.
